Skip to main content

IPO Chilli Ratings

IPO Chilli Ratings
Click to understand how it works

Featured

Posted by

Singapore Institute of Advanced Medicine Holdings Ltd

Singapore Institute of Advanced Medicine Holdings Ltd ("Sam" or the "Company") is offering 114m new shares comprising 4.415m Public Offer Shares and 109.585m Placement Shares at $0.23 each for a listing on Catalist.  The Company aims to raise $26.2m and the majority of the proceeds will be used to repay debt and the balance for working capital. The market cap based on the IPO price is $231.8m and the offer will close on 14 Feb at 12 noon and starts trading on 16 Feb 2024 at 9am.   Principal Business SAM is a healthcare service provider using advanced technology for early and accurate diagnosis to detect and treat cancer, neurodegenerative and cardiovascular diseases.  SAM has strategic collaborations with public and private institutions for research and clinical work.  SAM's goal is to create a comprehensive one-stop ambulatory cancer centre to undertake the challenges to fight cancer and is one of the first to adopt proto beam therapy treatment in Singapore. Fi
Post a Comment
Read more
Labels
Posted by

Q&M Dental Group (Singapore) Limited

Q&M Dental Group (Singapore) Limited (the "Company" or Q&M) is offering 74.075m shares at 27 Singapore cents. The offer is via placement only and the IPO will close on Nov 24 noon. Post IPO, the market cap is $74m . It is the first Dental pureplay to be listed on the mainboard of SGX and is one of the largest private dental healthcare group in Singapore.

Q&M plans to use close to 90% of IPO proceeds to fund new clinics and acqusitions.  It intends to make its foray into China first tier cities.  Revenue has grown from $24.3m in FY2006 to $29.6m in FY2008 and net profit has grown from $3.6m to $4.4m in the same period.  EPS for FY2008 is 1.6 cents based on the enlarged share cap and that represents 16.8x FY2009 earnings! Post IPO, the Company intends to distribute more than 50% of its net profit as dividend for 2H2009 and full year 2010. Assuming this year EPS is 1.6c (same as FY2008), the dividend payout will be 0.4 cents (2nd half only) and that translate into a yield of 3% (annualised) for FY2009.

The Company intends to expand aggressively ahead using the IPO proceeds and has injected a certain China play into this IPO and i guess that is what makes this IPO more 'interesting' than a pure Singapore dental play. As the IPO valuation is 'not cheap', investors will have to buy into the "story" that Q&M will be able to execute successfully in the fragmented China market. While the high "dividend" payout appears to be generous and attractive, it somewhat contradicts the cashflows needs of an "aggressive expansion plan".
Email Post
Labels:

Comments

Post a Comment